Cytovale: A Breakthrough Tool in The Fight Against Sepsis

Norwest relentlessly pursues opportunities to improve healthcare in the U.S. by partnering with companies that improve patient outcomes while lowering costs. Our latest investment is in just such a company: Cytovale, a pioneering medical diagnostics company that’s focused on advancing early detection and treatment of sepsis. We led the company’s $84 million Series C funding, […]

Diana Health: A Holistic Approach to Women’s Health

At Norwest, we strive to partner with companies that demonstrate a positive impact on all three “Ps” in the healthcare system: Patient, Provider, and Payor. Companies that align incentives and deliver benefits for all three stakeholders are all too rare in the U.S. healthcare system. So, we are excited when we see new models that […]